Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-80

Love the honesty Dr T - at the end of the day every ASX company has flaws so that’s nothing to be ashamed about!!

I don’t think RAC is a bad investment…. I do however think it is overvalued based on its asx peers but that is just my personal view….

And as far as not informing your shareholders of what you are doing…. When you get to that stage you will have to sign NDAs and it will all be sitting with the lawyers and you will have to go very quiet on here (not saying anything like that is happing over at the other one) but that’s just how it works!